Chagas Clinical Research Platform
Founded: 2009, Uberaba, Brazil
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to facilitate clinical research, provide a forum for technical discussions, develop a critical mass of expertise, and strengthen institutional research capacities. In addition, it will identifies and reviews priority needs, works towards standardization of methodology to assess drug efficacy and reviews alternatives for using current approved drugs (new schemes, doses, combination) and special scenarios (resistance).
‘Enabling discussions among researchers is an important tool for the improvement of efficiency, diagnosis and treatment.’
The Platform is active in:
- Treatments & access
- Clinical trials
- Capacity strengthening
- The number of CCRP members grew by 23%; about 40% of new members came from non-endemic countries.
- The annual Chagas Clinical Research Platform meeting took place in Buenos Aires, Argentina in the context of National Chagas Week, with 230 attendees from, among others, national programmes, patient associations, research associations, research and clinical care centres, NGOs and pharmaceutical companies.